8-K: Select Medical Holdings Reports Strong Q1 2024 Results, Announces Dividend and Reaffirms Outlook

Select Medical Holdings Corporation announced a robust first quarter for 2024, marked by significant revenue and profit growth, and declared a cash dividend.

Summary

• Select Medical Holdings Corporation reported a 7.4% increase in revenue to $1,788.8 million for the first quarter of 2024, compared to $1,665.0 million in the same period last year.
• Income from operations saw a substantial 28.1% increase, reaching $194.0 million, up from $151.5 million year-over-year.
• Net income rose by 37.4% to $117.2 million, compared to $85.3 million in the prior year's first quarter.
• Adjusted EBITDA increased by 22.4% to $261.9 million, up from $214.1 million year-over-year.
• Earnings per common share increased by 33.9% to $0.75, and adjusted earnings per common share increased by 37.5% to $0.77.
• The company operates 107 critical illness recovery hospitals, 33 rehabilitation hospitals, 1,922 outpatient rehabilitation clinics, and 547 occupational health centers as of March 31, 2024.
• A cash dividend of $0.125 per share was declared, payable on or about May 30, 2024, to shareholders of record as of May 16, 2024.
• Select Medical reaffirmed its 2024 revenue outlook, expecting between $6.9 billion and $7.1 billion, and adjusted its Adjusted EBITDA outlook to $845 million to $885 million.
• The company expects fully diluted earnings per share to be between $1.95 and $2.19, and adjusted earnings per share to be between $1.96 and $2.20 for 2024.

Sentiment

Score: 8

Explanation: The document presents a very positive outlook with strong financial results and a dividend declaration. The company is reaffirming its revenue outlook and adjusting its EBITDA and EPS outlook upwards. There are some risks mentioned, but the overall tone is optimistic.

Positives

• The company experienced significant growth across key financial metrics, including revenue, income from operations, net income, and adjusted EBITDA.
• All segments showed revenue growth, with the critical illness recovery and rehabilitation hospital segments showing the strongest growth.
• The company declared a cash dividend, indicating confidence in its financial position.
• The company reaffirmed its revenue outlook for 2024, demonstrating stability and predictability.
• The company has a stock repurchase program in place, which could enhance shareholder value.

Negatives

• The outpatient rehabilitation segment saw a decrease in Adjusted EBITDA and Adjusted EBITDA margin.
• The company did not repurchase any shares during the three months ended March 31, 2024, under its stock repurchase program.
• The company's general and administrative expenses increased by 14.6% year-over-year.

Risks

• Changes in government reimbursement policies could negatively impact revenue and profitability.
• Adverse economic conditions, including inflation, could increase labor and other costs.
• Shortages of qualified healthcare professionals could limit the company's ability to staff facilities.
• Public health threats, such as pandemics, could negatively impact patient volumes and revenues.
• Failure to maintain Medicare certifications could lead to a decline in revenue and profitability.
• Acquisitions or joint ventures may not be successful and could expose the company to unforeseen liabilities.
• Competition could limit the company's ability to grow and decrease revenue and profitability.
• Security breaches of information technology systems could lead to legal and reputational harm.

Future Outlook

Select Medical reaffirmed its 2024 revenue outlook of $6.9 billion to $7.1 billion and adjusted its Adjusted EBITDA outlook to $845 million to $885 million. The company expects fully diluted earnings per share to be between $1.95 and $2.19 and adjusted earnings per share to be between $1.96 and $2.20 for 2024.

Management Comments

• Select Medical is reaffirming its 2024 business outlook for revenue.
• Select Medical is adjusting its 2024 business outlook for Adjusted EBITDA and fully diluted earnings per share.
• Select Medical is also issuing its business outlook for adjusted earnings per share.

Industry Context

The healthcare industry is experiencing increased demand for services, which is reflected in Select Medical's strong performance. The company's diversified portfolio of critical illness recovery, rehabilitation, outpatient, and occupational health services positions it well to capitalize on these trends. The company's focus on operational efficiency and cost management is also contributing to its success.

Comparison to Industry Standards

• Select Medical's revenue growth of 7.4% is strong compared to some of its peers in the healthcare services sector, such as Encompass Health (EHC) which reported a 10.7% increase in net operating revenues for Q1 2024.
• The 22.4% increase in Adjusted EBITDA is also a strong result, indicating good operational efficiency. For comparison, HCA Healthcare (HCA) reported a 12.7% increase in adjusted EBITDA for Q1 2024.
• The company's adjusted EBITDA margin of 20.6% in the Concentra segment is comparable to other occupational health providers, such as U.S. Physical Therapy (USPH) which reported a 20.1% adjusted EBITDA margin for Q1 2024.
• The company's stock repurchase program is a common practice among publicly traded healthcare companies, such as Tenet Healthcare (THC), which also has an active share repurchase program.

Stakeholder Impact

• Shareholders will benefit from the increased profitability and the declared cash dividend.
• Employees may benefit from the company's growth and stability.
• Customers will continue to receive healthcare services from the company's facilities.
• Suppliers will continue to provide goods and services to the company.
• Creditors will be reassured by the company's strong financial performance.

Next Steps

• The company will host a conference call on May 3, 2024, to discuss the results and outlook.
• The company will pay a cash dividend on or about May 30, 2024.
• The company will continue its stock repurchase program through December 31, 2025, unless extended or terminated earlier.

Key Dates

Keywords

Select Medical, Healthcare, Financial Results, Dividend, EBITDA, Revenue, Earnings Per Share, Stock Repurchase, Critical Illness Recovery, Rehabilitation, Outpatient Services, Occupational Health